Literature DB >> 29055917

Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil - the Brazilian Global Burden of Disease Study.

Juliana R de Carvalho1, Cristiane A Villela-Nogueira2, Renata M Perez3, Flavia B Portugal4, Luisa S Flor5, Mônica R Campos5, Joyce M A Schramm5.   

Abstract

INTRODUCTION AND AIM: Data on epidemiology of liver diseases in Brazil is scarce. This study aimed to estimate the burden of chronic viral hepatitis and liver cirrhosis in the country.
MATERIALS AND METHODS: The indicator used was disability-adjusted life year (DALY), a sum of years of life lost due to premature mortality (YLL) and years lived with disability (YLD). Liver cirrhosis was analyzed in etiologic categories and cirrhosis of viral origin was considered part of the burden of chronic hepatitis.
RESULTS: There were 57,380 DALYs (30.3 per 100,000 inhabitants) attributable to chronic hepatitis B and cirrhosis due to hepatitis B, with 41,262 DALYs in men. Most burden was caused by YLL (47,015 or 24.8/100,000) rather than YLD (10,365 or 5.5/100,000). Chronic hepatitis C and cirrhosis due to hepatitis C were responsible for 207,747 DALYs (109.6/100,000), of which 137,922 were YLL (72.7/100,000) and 69,825 (36.8/100,000) were YLD, with a higher proportion of DALYs in men (73.9%). Cirrhosis due to alcohol or other causes had a total of 536,169 DALYs (1,4% of total DALYs in Brazil), with 418,272 YLL (341,140 in men) and 117,897 YLD (97,965 in men). Highest DALYs' rates occurred at ages 60-69 in chronic hepatitis and at ages 45-59 in cirrhosis due to alcohol or other causes.
CONCLUSION: Chronic viral hepatitis and liver cirrhosis are responsible for a significant burden in Brazil, affecting mainly men and individuals still in their productive years. Most burden is related to non-viral causes of cirrhosis, with a major contribution of alcohol.

Entities:  

Keywords:  Epidemiology. Hepatitis B. Hepatitis C. Liver diseases. Public health.

Mesh:

Year:  2017        PMID: 29055917     DOI: 10.5604/01.3001.0010.5280

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  4 in total

1.  The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017.

Authors:  Mimi Zhai; Zhide Liu; Jianhai Long; Qingxiang Zhou; Leping Yang; Qin Zhou; Sushun Liu; Yu Dai
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

2.  The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017.

Authors:  Mimi Zhai; Jianhai Long; Sushun Liu; Chun Liu; Li Li; Leping Yang; Yamin Li; Bo Shu
Journal:  Aging (Albany NY)       Date:  2021-01-12       Impact factor: 5.682

3.  Global research trends in the field of liver cirrhosis from 2011 to 2020: A visualised and bibliometric study.

Authors:  Pei-Ling Gan; Shu Huang; Xiao Pan; Hui-Fang Xia; Xin-Yi Zeng; Wen-Sen Ren; Xian Zhou; Mu-Han Lv; Xiao-Wei Tang
Journal:  World J Gastroenterol       Date:  2022-09-07       Impact factor: 5.374

4.  Risk of New-Onset Atrial Fibrillation Among Asian Chronic Hepatitis C Virus Carriers: A Nationwide Population-Based Cohort Study.

Authors:  Yao-Hsu Yang; Hsin-Ju Chiang; Hon-Kan Yip; Ko-Jung Chen; John Y Chiang; Mel S Lee; Pei-Hsun Sung
Journal:  J Am Heart Assoc       Date:  2019-11-12       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.